Q: "Are you using mapping capabilities prior to fixation?
A: “Absolutely. It takes about less than a minute, and it cuts down the number of times you have to re-capture and re-implant. I think that adds a huge safety factor. Because the more re-captures you have, at least with the Micra device, we know that the more re-captures we have, the higher the perforation risks, and the higher the risk for pericardial effusion. So if I can cut down that re-capture need, absolutely. I'll take that minute to map every single time.”
Abbott’s AVEIR™ VR Leadless Pacemaker (LP) Late-Breaking Clinical Update and Case Studies webinar on November 9 featured an insightful 20-minute live Q&A session following a discussion on the latest clinical data, main advantages, and a review of case studies with expert implanters.
Dr. Vivek Reddy, MD
Director of Cardiac Arrhythmia Services,
Mount Sinai Medical Center
Dr. Larry Chinitz, MD
Director of the Heart Rhythm Center, NYU
Langone Medical Center
Dr. Rahul Doshi, MD
Pillar Chief Complex Arrhyhtmia Management,
Dr. Devi Nair, MD, FACC, FHRS
Director of Cardiac Electrophysiology
St. Bernard's Healthcare
Dr. Anne Kroman, DO, PhD
Medical University of South Carolina Health
Dr. Cyrus Hadadi, MD
Associate Director of Cardiac Arrythmia Research,
Medstar Washington Hospital Center
After sharing perspectives on the present and future of leadless technology, the panelists fielded live questions on a variety of topics, including implant location orientation, differences between Abbott’s AVEIR VR Leadless Pacemaker and competitors, mapping with patients (highlighted above), how it will revolutionize pacing, plus change and benefit the practice in the future and more.
Watch the AVEIR VR Leadless Pacemaker late-breaking clinical update and case studies Webinar, including the Q & A session below and learn more about the Aveir VR Leadless Pacemaker's capabilities here.
MAT-2214857 v2.0 | Item is approved for US use only